11/14/2024
5:55 AM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:17 PM | Lamond David (Filed by)
Quince Therapeutics (Subject)
| Form SC 13D | |
11/13/2024
4:09 PM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:15 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:38 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
4:51 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
5:38 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/13/2024
3:11 PM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2024
7:04 PM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SC 13G/A | |
06/07/2024
8:08 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:55 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:57 PM | Benatti Luca (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:59 PM | Bray June (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:00 PM | Quince Therapeutics (Issuer)
Senner Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:03 PM | Quince Therapeutics (Issuer)
RYAN UNA S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
8:04 PM | McLoughlin Margaret (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:17 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
1:37 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
6:30 AM | Quince Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:05 PM | Quince Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:10 PM | Quince Therapeutics (Filer)
| Form ARS | |
04/11/2024
3:39 PM | Quince Therapeutics (Filer)
| Form PRE 14A | |
04/01/2024
4:21 PM | Quince Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/01/2024
3:50 PM | Quince Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
5:09 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/15/2024
5:14 PM | Patni Rajiv (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
8:00 AM | Quince Therapeutics (Subject)
Sofinnova Partners SAS (Filed by)
| Form SC 13G | |
02/07/2024
9:50 AM | BML Investment Partners, L.P. (Filed by)
Quince Therapeutics (Subject)
| Form SC 13G/A | |
02/02/2024
5:02 PM | Quince Therapeutics (Issuer)
Ryan Charles S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:50 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:53 PM | Hannah Brendan (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:00 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:48 PM | Quince Therapeutics (Issuer)
Thye Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
3:08 PM | Quince Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:21 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:30 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
12:38 PM | Lamond David (Reporting)
Quince Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free QNCX Stock Alerts